Prenetics Global Limited

NASDAQ:PRE

Medical - Diagnostics & Research

Healthcare
$10.35 +2.19%

+$0.43 today

Market cap
$185.61M
Beta
0.24
P/E (TTM)
-4.9
EPS (TTM)
-$4.18
52W Low $7.18High $23.63

Volume 1.58M

Average 0.22M

PRE Short-term Investments

Marketable securities and deposits the company expects to convert to cash within a year.

Prenetics Global LimitedNASDAQ: PRE

Short-term Investments · Q1 FY2026 · quarter ended Mar 2026

Short-term investments rises 373.6% from a year ago

Short-term investments stood at $50.02M at the end of Q1 FY2026, up 373.6% from a year earlier and up 70.4% from the prior quarter. Over 3 fiscal years it compounded at -7.8% a year.

Context

  • Short-term investments amounted to 28.5% of total assets at the end of Q1 FY2026, up 23.4 pp from a year earlier.
  • Short-term investments increased in 1 of the last 3 fiscal years.

What to watch

Whether short-term investments keeps rising in the next quarterly balance sheet after a +373.6% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$50.02M+70.4% QoQ
Last fiscal yearDec 2025
$29.36M+177.9% YoY
Year agoMar 2025
$10.56M+373.6% since
Short-term Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+373.6%——
1 year+177.9%——
3-year CAGR-7.8%——
5-year CAGR——
10-year CAGR——

Short-term Investments history

USD · from the balance sheet

Latest · FY2025
29.36M USD
Year-over-year change
+177.9%
4-year CAGR
+31.2%

Short-term Investments vs competitors

How PRE compares with its peers on the latest reported figures

  • PRE's Mar 2026 short-term investments of $50.02M is the highest of the 11 companies compared; the peer median is $0.
  • Its year-over-year change of +373.6% is the highest of 4, against a peer median of -100.0%.
  • Short-term investments amounts to 28.5% of total assets for PRE, versus a peer median of 0.0%.
PRE Competitors Peer median
Short-term Investments for PRE and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
PREPrenetics Global LimitedMar 2026$50.02M +373.6%-7.8%28.5%
CDXSCodexis, Inc.Mar 2026$28.57M -31.1%—22.1%
PROFProfound Medical Corp.Mar 2026$0 ——0.0%
OSUROraSure Technologies, Inc.Mar 2026$0 ——0.0%
TLSITriSalus Life Sciences, Inc.Mar 2026$0 ——0.0%
ARMPArmata Pharmaceuticals, Inc.Mar 2026$0 ——0.0%
MXCTMaxCyte, Inc.Mar 2026$0 -100.0%-27.3%0.0%
STIMNeuronetics, Inc.Mar 2026$0 -100.0%-47.3%0.0%
IMDXInsight Molecular Diagnostics Inc.Mar 2026$0 ——0.0%
ATLNAtlantic International Corp.Dec 2025$0 ——0.0%
SGMOSangamo Therapeutics, Inc.Mar 2026$0 ——0.0%
Peer median (excluding PRE) $0-100.0%-37.3%0.0%

Competitors are the stored peer set for PRE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents35.29M146.66M45.71M52.25M32.13M
Short-term Investments9.91M37.46M27.03M10.56M29.36M
Net Receivables47.05M42.5M5.29M5.61M2.98M
Inventory6.83M4.53M3.13M6.57M7.06M
Other Current Assets7.31M4.58M8.31M3.55M11.86M
Total Current Assets106.89M241.81M93.66M86.15M83.39M
Property, Plant & Equipment (Net)13.04M13.1M5.78M7.81M1.76M
Goodwill3.98M33.8M29.17M37.36M0
Intangible Assets23.83M14.79M13.43M11.57M44.7M
Long-term Investments0788.47K107.84M69.33M67M
Tax Assets79.7K243.45K28K00
Other Non-current Assets693.55K7.6M4.27M1.35M6.68M
Total Non-current Assets41.61M70.32M160.51M127.43M120.13M
Total Assets148.51M312.13M254.17M213.58M203.52M
Account Payables9.98M7.29M1.67M3.67M7.73M
Short-term Debt1.67M0001.33M
Tax Payables1.22M8.65M7.44M78K0
Deferred Revenue9.59M5.67M6.11M6.49M3.09M
Other Current Liabilities22.64M17.47M15.49M15.07M15.5M
Total Current Liabilities58.74M57.2M39.48M36.55M27.67M
Long-term Debt486.4M000437K
Deferred Tax Liabilities659.5K3.19M2.62M2.17M8K
Deferred Revenue (Non-current)00000
Other Non-current Liabilities04.52M1.05M499K460K
Total Non-current Liabilities490.66M11.47M4.53M5.68M1.34M
Total Liabilities549.4M68.67M44.01M42.23M29.01M
Common Stock1.49K13.7K18K19K25K
Retained Earnings0(408.04M)(470.77M)(517.07M)0
Accumulated OCI(400.81M)(185.69M)(176.03M)(169.25M)0
Other Stockholders Equity(24K)000174.58M
Minority Interest(84.98K)6.4M3.8M957K(93K)
Total Equity(400.89M)243.46M210.16M171.35M174.51M
Total Debt491.67M6.65M2.37M5.77M2.2M
Net Debt456.38M(140.01M)(43.34M)(46.48M)(29.93M)

Prenetics Global Limited

NASDAQ:PRE

Intrinsic Alpha fair value

Locked

Current Price

$10.35

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.